Short Interest in GlucoTrack, Inc. (NASDAQ:GCTK) Declines By 98.0%

GlucoTrack, Inc. (NASDAQ:GCTK) saw a significant drop in short interest in May. As of May 15th, there was short interest totaling 44,035 shares, a drop of 98.0% from the April 30th total of 2,166,796 shares. Approximately 0.7% of the shares of the stock are sold short. Based on an average daily trading volume, of 9,850,067 shares, the short-interest ratio is presently 0.0 days.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of GlucoTrack in a report on Tuesday, April 21st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, GlucoTrack currently has a consensus rating of “Sell”.

GlucoTrack Trading Up 8.0%

Shares of GCTK stock traded up $0.05 during mid-day trading on Wednesday, hitting $0.64. 1,596,492 shares of the company’s stock were exchanged, compared to its average volume of 10,925,522. GlucoTrack has a fifty-two week low of $0.43 and a fifty-two week high of $15.90. The stock has a 50-day simple moving average of $0.78 and a two-hundred day simple moving average of $2.62. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.08. The stock has a market cap of $3.99 million, a price-to-earnings ratio of -0.04 and a beta of 0.78.

Institutional Investors Weigh In On GlucoTrack

Several hedge funds have recently made changes to their positions in GCTK. Bank of America Corp DE boosted its holdings in shares of GlucoTrack by 102,125.0% during the second quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after purchasing an additional 4,085 shares during the last quarter. Boothbay Fund Management LLC purchased a new stake in GlucoTrack during the fourth quarter valued at about $52,000. Finally, Ikarian Capital LLC purchased a new stake in GlucoTrack during the fourth quarter valued at about $177,000. Institutional investors and hedge funds own 10.92% of the company’s stock.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.